Old Web
English
Sign In
Acemap
>
authorDetail
>
R. S. Allen
R. S. Allen
Sunesis Pharmaceuticals
Refractory
Vosaroxin
Medicine
Cancer research
Quinolone
2
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia
2011
Leukemia
Jeffrey E. Lancet
Farhad Ravandi
Rebecca M. Ricklis
Larry D. Cripe
Hagop M. Kantarjian
Francis J. Giles
Alan F. List
Tianling Chen
R. S. Allen
Judith A. Fox
Glenn Michelson
Judith E. Karp
Show All
Source
Cite
Save
Citations (39)
Adaptive design of VALOR, a phase III trial of vosaroxin or placebo in combination with cytarabine for patients with first relapsed or refractory acute myeloid leukemia.
2011
Journal of Clinical Oncology
Cyrus R. Mehta
Glenn Michelson
M. Salganik
J. Feaster
R. S. Allen
Ann Cahill
Judith A. Fox
S.B. Ketchum
Farhad Ravandi
Harry P. Erba
Gary J. Schiller
Robert K. Stuart
Norbert Vey
Eric J. Feldman
Show All
Source
Cite
Save
Citations (5)
1